Novavax Inc (NVAX)

EBITDA Margin

-49.68%

TTM · Period ending:

NVAX logo

NVAX EBITDA Margin

Latest reported-49.68%
NVAX EBITDA Margin (-5200.00% → -49.68%)
High-resolution chart · PNG

NVAX ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
43.8216%
-15.8385%
-87.5999%
-37.8194%
-850.6628%
-1,778.7609%
-607.6841%
-475.3179%
-512.8304%
-1,683.684%
-415.76%
-255.6052%
-235.2713%
-121.4396%
-117.9875%
-10,410.4956%
-11,807.3846%
-3,171.6165%
-1,889.6233%
-390.5189%
-72.6313%
-254.5157%
-126.1604%
-136.088%
-23.9591%
-490.8283%
-350%
-700%
-900%
-5,200%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.